David Kroin has an estimated net worth of $1.37 Billion. This is based on reported shares across multiple companies, which include MEDecision, Inc., Foamix Pharmaceuticals Ltd., InfuSystem Holdings, Inc, Adamas Pharmaceuticals Inc, CONNECTURE INC, CAPRIUS INC, MEMORY PHARMACEUTICALS CORP, Biodel Inc, NEKTAR THERAPEUTICS, DYNAVAX TECHNOLOGIES CORP, and LB PHARMACEUTICALS INC.

2015 was David Kroin's most active year for acquiring shares with 4 total transactions. David Kroin's most active month to acquire stocks was the month of May. 2009 was David Kroin's most active year for disposing of shares, totalling 81 transactions. David Kroin's most active month to dispose stocks was the month of June. 2025 saw David Kroin paying a total of $39,999,990.00 for 3,352,804 shares, this is the most they've acquired in one year. In 2025 David Kroin cashed out on 18,731,804 shares for a total of $22,351,598.19, their largest year based on trade value.